Shoei Yakuhin Co.,Ltd.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/08/01Dividend History 3Years Growth
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥46 | +17.9% |
| 2025 | ¥39 | +2.6% |
| 2024 | ¥38 | +5.6% |
| 2023 | ¥36 | -14.3% |
| 2022 | ¥42 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥24,529M | ¥22,596M | ¥25,013M | ¥26,922M |
| Gross Profit | ¥1,886M | ¥1,892M | ¥2,099M | ¥2,164M |
| Operating Income | ¥488M | ¥440M | ¥560M | ¥505M |
| Pretax Income | ¥676M | ¥652M | ¥758M | ¥725M |
| Net Income | ¥485M | ¥492M | ¥527M | ¥557M |
| EPS | ¥141.83 | ¥144.75 | ¥154.78 | - |
| Operating Margin | 1.99% | 1.95% | 2.24% | 1.87% |
| Balance Sheet | ||||
| Total Assets | ¥14,798M | ¥16,816M | ¥17,098M | ¥17,806M |
| Total Equity | ¥7,370M | ¥8,138M | ¥8,936M | ¥9,416M |
| Total Liabilities | ¥7,428M | ¥8,678M | ¥8,162M | ¥8,390M |
| Cash | ¥1,527M | ¥2,191M | ¥1,912M | ¥1,453M |
| Interest-bearing Debt | ¥650M | ¥600M | ¥600M | ¥150M |
| Equity Ratio | 49.81% | 48.39% | 52.26% | 52.88% |
| D/E Ratio | 0.09 | 0.07 | 0.07 | 0.02 |
| Cash Flow | ||||
| Operating CF | ¥645M | ¥818M | -¥172M | ¥104M |
| Investing CF | -¥30M | -¥18M | -¥21M | ¥317M |
| Financing CF | -¥269M | -¥172M | -¥129M | -¥583M |
| Free CF | ¥635M | ¥818M | -¥179M | ¥101M |
| Efficiency | ||||
| ROE | 6.57% | 6.04% | 5.90% | 5.92% |
| ROA | 3.27% | 2.93% | 3.08% | 3.13% |
Latest IR Information
-
Shouei Pharmaceutical Corporate First Quarter Financial Results Report (Japanese Standards)
For the first quarter of the fiscal year ending March 2027, the sales are expected to increase versus the previous period, with operating income and net income also higher than the year-ago quarter. Segment-by-segment sales and profitability trends, as well...
Read more -
Share Buyback of Restricted Stock Compensation｜July 2026
Showei Pharmaceutical will dispose of 7,500 shares of treasury stock on August 17, 2026, raising a total of 12,412,500 yen. This is part of a stock compensation program aimed at incentivizing targeted directors.
Read more -
Response to Achieving Management that Considers Cost of Capital and Stock Prices (Update)
This document discusses updates to measures aimed at achieving management that considers the cost of capital and stock prices, explaining specific strategies and evaluation schemes.
Read more -
Notice Regarding the Summary of the Effectiveness Assessment of Our Company's Board of Directors
Read more
Latest News (5 items)
Company Information
About
Shoei Yakuhin Co.,Ltd., together with its subsidiaries, engages in trading of chemicals, daily necessities, and civil engineering and construction materials in Japan and internationally. The company provides various oleo chemicals, such as fatty acids, aliphatic amines, aliphatic alcohols, and glycerin; and petrochemicals, synthetic resins, solvents and mineral oils, pigments, and anionic, nonionic, fatty amines, fatty alcohols, cationic, and amphoteric surfactants, as well as inorganic chemicals, cosmetics, and fragrances, which sell to manufacturers of automotive parts, home appliances, electronic components, daily necessities, and FRP products. It also offers daily necessities, including household detergents, industrial-grade cleaners, deodorizers, and cosmetics. Further, it offers civil engineering and construction materials, such as ground stabilization grouts; repairing and reinforcing concrete materials and additives; soil improving agents; and other products. The company was founded in 1937 and is headquartered in Osaka, Japan.
